Clobetasol

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: D07AD01

Side effects

Options: Show MedDRA Preferred Terms, display all 22 labels

Side effect	Data for drug	Labels
		1	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17	18	19	20
Infection	10% - 14.2%																		x	x
Infestation NOS	10% - 14.2%																		x	x
Application site burn	10% - 46.7%													x	x			x	x	x
Upper respiratory tract infection	1.67% - 8.33%																		x	x
Discomfort	1.3% - 12.6%				x	x							x			x					x
Skin atrophy	4.2%	x	x		x	x	x	x	x	x	x	x	x	x	x	x	x	x			x
Nasopharyngitis	2.5% - 5%																		x	x
Telangiectasia	3.2%	x			x	x	x	x	x	x	x	x	x	x	x	x		x			x
Application site pruritus	2.5% - 3.33%																		x	x
Unspecified disorder of skin and subcutaneous tissue	1.67% - 3.33%																		x	x
Headache	0.787% - 1.79%															x	x				x
Application site pain	0.833% - 1.67%																		x	x
Dry skin	1%				x	x						x	x			x					x
Influenza	0% - 1.67%																			x
Asteatosis	0% - 1.67%																		x	x
Pruritus	postmarketing, 0.538% - 7.09%	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x		x
Application site dryness	0% - 1.67%													x	x			x	x	x
Pharyngitis streptococcal	0% - 0.833%																		x	x
Application site atrophy	0% - 0.833%			x																x
Application site irritation	0% - 0.833%																		x	x
Application site pigmentation changes	0% - 0.833%																		x	x
Alopecia	postmarketing			x								x				x	x				x
Cushing's syndrome	postmarketing		x	x			x	x	x	x	x	x	x	x	x	x	x	x	x	x	x
Dermatitis contact	postmarketing																		x
Dizziness	postmarketing																				x
Endocrine disorder	postmarketing												x								x
Rash	postmarketing												x						x		x
Excoriation	postmarketing												x
Lichenification	postmarketing												x
Nausea	postmarketing																				x
Pain	postmarketing																		x
Psoriasis	postmarketing												x								x
Erythema	postmarketing	x		x	x	x	x	x	x	x	x		x	x	x			x	x		x
Urticaria	postmarketing											x				x			x		x
Eye pain	postmarketing																				x
Skin irritation	postmarketing																				x
Allergic contact dermatitis	postmarketing		x	x	x	x	x	x	x	x		x		x	x	x	x	x		x	x
Eye irritation	postmarketing																x				x
Skin exfoliation	postmarketing												x								x
Pain of skin	postmarketing												x								x
Skin tightness	postmarketing																				x
Secondary adrenocortical insufficiency	postmarketing												x	x	x			x			x
Induration	postmarketing												x
Vision blurred	postmarketing																				x
Hair colour changes	postmarketing																				x
Localized exfoliation	postmarketing																		x
Chapped skin	postmarketing												x
Dermatitis																	x
Oedema												x				x					x
Folliculitis		x		x	x	x	x	x	x	x	x	x	x	x	x	x	x	x		x	x
Glycosuria											x	x	x	x	x	x	x	x	x	x	x
Hyperglycaemia											x	x	x	x	x	x	x	x	x	x	x
Hypertrichosis								x	x	x	x			x	x		x	x
Miliaria			x	x	x	x	x	x	x	x	x	x		x	x	x	x	x		x
Burning sensation							x		x		x
Application site reaction				x
Skin striae			x	x	x	x	x	x	x	x	x	x		x	x	x	x	x		x
Dermatitis irritant contact												x				x					x
Leukoderma			x	x	x	x	x	x	x	x	x	x		x	x	x	x	x		x
Acneiform eruption			x	x	x	x	x	x	x	x	x			x	x		x	x		x
Tenderness		x						x		x							x
Pustule																	x
Dermatitis perioral			x	x	x	x	x	x	x	x	x	x		x	x	x	x	x		x
Atopy																		x
Secondary infection			x	x	x	x	x	x	x	x	x	x		x	x	x	x	x		x
Numbness in fingers		x					x	x	x	x	x			x	x			x
Stinging		x	x		x	x	x	x	x	x	x	x	x	x	x	x	x	x			x
Tingling sensation																	x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Indication
Dermatitis atopic		x	x	x							x
Non-scalp psoriasis													x		x
Plaque psoriasis			x	x												x
Psoriasis		x	x	x		x		x	x		x	x		x
Psoriasis of scalp										x
Skin disorder	x		x		x	x	x	x	x			x	x	x	x

Side effects:	8
Source:	FDA Structured Product Label

Side effects:	11
Source:	FDA Structured Product Label

Side effects:	14
Source:	FDA Structured Product Label

Side effects:	15
Source:	FDA Structured Product Label

Side effects:	15
Source:	FDA Structured Product Label

Side effects:	16
Source:	FDA Structured Product Label

Side effects:	17
Source:	FDA Structured Product Label

Side effects:	17
Source:	FDA Structured Product Label

Side effects:	17
Source:	FDA Structured Product Label

Side effects:	18
Source:	FDA Structured Product Label

Side effects:	19
Source:	FDA Structured Product Label

Side effects:	21
Source:	FDA Structured Product Label

Side effects:	21
Source:	FDA Structured Product Label

Side effects:	21
Source:	FDA Structured Product Label

Side effects:	21
Source:	FDA Structured Product Label

Side effects:	22
Source:	FDA Structured Product Label

Side effects:	22
Source:	FDA Structured Product Label

Side effects:	23
Source:	FDA Structured Product Label

Side effects:	26
Source:	FDA Structured Product Label

Side effects:	31
Source:	FDA Structured Product Label

Color scheme:

standard – alternative

		100%
		75%
		50%
		10%
		frequent (1% to 100%)
		infrequent (0.1% to 1%)
		rare (<0.1%)
		postmarketing
		0%
		no frequency information
		not found on label

Search results :

Clobetasol

Side effects

Indications

clobetasol

Clobetasol

CLOBETASOL

CLOBETASOL

Clobetasol

Clobetasol

Clobetasol

CLOBETASOL

CLOBETASOL

CLOBETASOL

CLOBETASOL

CLOBETASOL

CLOBETASOL

CLOBETASOL

clobetasol

Clobetasol

CLOBETASOL

CLOBETASOL

CLOBETASOL

CLOBETASOL

Color scheme: